Oil refiner Phillips 66 plans to acquire EPIC NGL in $2.2 billion deal-May 2024-www.financetom.com

Oil refiner Phillips 66 plans to acquire EPIC NGL in $2.2 billion deal

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Oil refiner Phillips 66 plans to acquire EPIC NGL in $2.2 billion deal

Jan 6, 2025 4:17 PM

(Reuters) - U.S. oil refiner Phillips 66 said on Monday it will acquire EPIC Y-Grade GP and EPIC Y-Grade in an all-cash deal for $2.2 billion.

The transaction is expected to be immediately accretive to earnings per share upon close, it added.

Previous page： QUOTES-Soccer-Reaction to Manchester United sacking manager Erik Ten Hag Next page： QatarEnergy takes 50% stake in TotalEnergies solar project in Iraq

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

QUOTES-Soccer-Reaction to Manchester United sacking manager Erik Ten Hag

Nov 3, 2024

Oct 28 (Reuters) - Manchester United ( MANU ) have sacked manager Erik ten Hag, with the team languishing 14th in the Premier League table after nine games, the club said in a statement on Monday. United have appointed the club's assistant manager and ex-striker Ruud van Nistelrooy as the new boss at Old Trafford on an interim basis, the...

QatarEnergy takes 50% stake in TotalEnergies solar project in Iraq

Nov 3, 2024

DUBAI (Reuters) - QatarEnergy, one of the world's top suppliers of liquefied natural gas, said on Monday it had agreed to take a 50% stake in TotalEnergies' 1.25-gigawatt solar project in Iraq. The French energy giant will retain the remaining 50% stake in the project, which is part of Iraq's $27 billion Gas Growth Integrated Project (GGIP), QatarEnergy said in...

Neurosense, FDA to Meet Nov. 6 to Discuss Design of Amyotrophic Lateral Sclerosis Treatment Trial; Shares Rise

Nov 3, 2024

10:47 AM EDT, 10/28/2024 (MT Newswires) -- NeuroSense Therapeutics ( NRSN ) said Monday it is scheduled for a type C meeting with the US Food and Drug Administration Nov. 6 to discuss the design of a phase 3 clinical trial for its lead drug candidate PrimeC for the potential treatment of amyotrophic lateral sclerosis. The company plans to provide...

Verb Technology Regains Nasdaq Compliance; Investigates Potential Price Manipulation

Nov 3, 2024

10:52 AM EDT, 10/28/2024 (MT Newswires) -- Verb Technology ( VERB ) said Monday it regained compliance with Nasdaq's minimum bid price requirement for continued listing. The company said it received the compliance notice from Nasdaq on Oct. 23. Verb Technology ( VERB ) also said it has initiated an investigation into suspected stock manipulation following its 1-for-200 reverse stock...